Title: Clinical efficacy of Xieliyinyang decoction on perimenopause syndrome
Abstract: AIM To study clinical efficacy of Xieliyinyang decoction on perimenopause syndrome.METHODS A total of 318 patients with perimenopause syndrome were divided into 2 groups at random:the test group(212 patients, treated with a dose of Xieliyinyang decoction,po,bid for 21 d) and the control group(106 patients,treated with 4 geng-nian'an tablets,po,bid for 21 d).Before and after treatment,patients in 2 groups were scored according to their clinical symptoms.Meanwhile,serum follicle-stimulating hormone(FSH) and estradiol(E_2) of patients in the test group were observed respectively.RESULTS The clinical effective rate of the test group was 98.60%,and that of the control group was 91.50%,P0.01.Before and after treatment,serum FSH of patients in the test group was(58.79±30.86) mIU·L~(-1) and(59.34±29.33) mIU·L~(-1) respectively,P 0.05;serum E_2 of patients in the test group was(30.18±42.16) pg·L~(-1) and(40.60±42.16) pg·L~(-1) respectively,P0.05.CONCLUSION Xieliyinyang decoction could increase serum E_2 level effectively and improve perimenopause syndrome.
Publication Year: 2011
Publication Date: 2011-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot